Drug utilization pattern evaluation and cost variation analysis of anti-fungal agents in tinea infected patients in dermatology department of a tertiary care teaching hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20233906Keywords:
Cost variability, Drug utilization pattern, Tinea infectionAbstract
Background: Tinea infections are chronic superficial fungal infections, highly prevalent in tropical countries like India. Therefore, long-term therapy is needed and this can inflict a financial burden on the patients. Aim of the study was to assess drug utilization patterns in patients diagnosed with tinea infection and to evaluate the cost variability of anti-fungal agents.
Methods: A cross-sectional observational study was conducted in patients for 3 months after taking permission from IEC. All adult patients already diagnosed with tinea infection were enrolled. Evaluation of drug utilization pattern was carried out using WHO core drug prescribing indicators and percentage of cost variability was calculated between different brands of anti-fungal agents.
Results: A total of 252 patients were enrolled. Tinea corporis and cruris were the most commonly diagnosed tinea infection. Pruritus was the most common presenting symptom. Past history of similar illness was seen in 74 (29.4%) patients mean of 3.83±0.87 drugs were prescribed per patient. Drugs prescribed from NLEM was only 42.1%. Most commonly prescribed drugs were oral itraconazole and topical miconazole. Percentage of cost variability was seen maximum with capsule itraconazole 200 mg (237.5%) by oral route and luliconazole 30 gm (175.6%) by topical route.
Conclusions: Prescribing practices of drugs can be improved by promoting generic drug and prescribing drugs from NLEM. Wide range of cost variation can lead to high economic burden in tinea infected patients.
Metrics
References
Verma SB, Panda S, Nenoff P, Archana S, Shivprakash MR, Silke U, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J Dermatol Venereol Leprol. 2021;87(2):154-75.
Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: Data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens. 2008;21(7):789-98.
Verma SB, Zouboulis C. Indian irrational skin creams and steroid-modified dermatophytosis – an unholy nexus and alarming situation. J Eur Acad Dermatology Venereol. 2018;32(11):e426-7.
Verma S, Madhu R. The great Indian epidemic of superficial dermatophytosis: An appraisal. Indian J Dermatol. 2017;62(3):227-36.
Amiri R, Shirooei B, Bharat KL, Hajatifard S. Drug utilization evaluation of antifungal agents in outpatients visiting the dermatology department of a tertiary care hospital in India. 2022;11(6):977-83.
Bagchi C, Mukherjee S, Chatterjee K. An outpatient-based observational study on demography, self-medication practice, and prescribing pattern in dermatophytosis at a tertiary care teaching hospital in Eastern India. Natl J Physiol Pharm Pharmacol. 2022;12(8):1.
Kandra N. Cost variation analysis of different brands of antifungal drugs available in India. Natl J Physiol Pharm Pharmacol. 2021;12(0):1.
Oberoi S, Oberoi A. Pharmacoeconomics guidelines: The need of hour for India. Int J Pharm Investig. 2014;4(3):109-11.
Vegada BN, Karelia BN, Singh AP. Drug utilization study of antifungal agents used in department of skin and V.D. of a tertiary care teaching hospital. Int J Pharm Sci Rev Res. 2015;34(1):118-21.
Joshi S, Shrestha S, Timothy U, Jha A, Thapa D. Health Seeking Behavior and Cost of Care of Chronic Dermatophytosis: A Hospital-Based Cross-Sectional Study. Nepal Med Coll J. 2020;22(3):181-8.
Dutta B, Rasul ES, Boro B. Clinico-epidemiological study of tinea incognito with microbiological correlation. Indian J Dermatol Venereol Leprol. 2017;83(3):326-31.
Mahajan SA, Deshmukh SS, Rawal JR. Observational cross-sectional study to evaluate the effects of self-medication with topical agents used by patients for superficial fungal skin infection at tertiary care hospital in Mumbai. Int J Basic Clin Pharmacol. 2020;9(5):796.
Bulwi F Al, Jamal MBAL, Zahrani R Al. Analysis of Drug Utilization and Prescribing Pattern in Dermatology Opd in Tertiary Care Hospital, Saudi Arabia. 2019;8(11):61-71.
Poudyal Y, Joshi SD. Medication practice of patients with dermatophytosis. J Nepal Med Assoc. 2016;55(203):7-10.
Gopimohan P, Pillai RT. A study on the prescription pattern of antifungal drugs in the Dermatology Department of a tertiary care teaching hospital in Southern Kerala. Int J Basic Clin Pharmacol. 2018;8(1):100-3.
Bansal P, Baishnab S, Singla A. Drug prescribing pattern of antifungal drugs for local fungal infections in a tertiary care hospital: MAMC, Agroha. Int J Basic Clin Pharmacol. 2021;10(6):689-93.
Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of drug utilization pattern for skin diseases in dermatology opd of an indian tertiary care hospital - A prescription survey. J Clin Diagnostic Res. 2016;10(2).
Spoorthy HV, Padma L, Srividya P. Analysis of cost of various topical and oral antifungal drugs for superficial fungal infections available in India. Int J Basic Clin Pharmacol. 2021;10(12):1348-51.
Naaz R, Shetty S, Chand S, Nandakumar UP, Vinay BC, Bharath Raj KC. Prospective observational study on prescribing pattern of antifungal drugs among the 400 out-patients in department of dermatology in a tertiary care hospital. Biomed Pharmacol J. 2021;14(1):311-6.
